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IN VITRO STUDIES OF THE ANTIFUNGAL ANTIBIOTIC GRISEOFULVIN*
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The therapeutic efficacy of orally administered
griseofulvin for the treatment of superficial
fungous infections due to dermatophytes seems
established. This antibiotic was first isolated by
Oxford and coworkers (1) from Penicillium
griseofulvin in 1939. In 1946, Brian et at. (2) ob-
served that cultures of P. janczewskii produced a
factor which caused stunting of germ tubes of
Botrytis allii. Grove (3) subsequently showed that
this "curling factor" was identical to griseofulvin
and established its chemical structure. The anti-
biotic was employed agriculturally to prevent
botrytis wilt of lettuce and alternaria blight of
tomatoes. (4)
In 1958, Gentles (5) reported the value of
griseofulvin administered by the oral route in
the treatment of experimental dermatophytoses
in animals. Guinea pigs experimentally infected
with Micros porum canis were treated successfully
with an oral dose of 60 mg./kg. of the antibiotic.
Treatment was begun ten days after infection
and clinical benefits were demonstrated within
four days after onset of therapy. By the eighth
day of treatment nearly all hair follicles were
devoid of fungal elements and hair formed sub-
sequent to therapy resisted completely further
invasion by the dermatophyte. Other experi-
ments showed that griseofulvin was strikingly
effective in curing guinea pigs experimentally
infected with Trichophyton mentagrophytes.
Gentles states (6) that in recent work he has
found 15 mg./kg. curative in guinea pigs.
In an amplification of the initial report by
Gentles, Martin (8) showed that experimental
dermatophytoses in guinea pigs is controlled by
oral doses of 25 to 100 mg./kg. of griseofulvin.
He observed that the topical application of 1
per cent griseofulvin ointment suppressed the
development of cutaneous lesions if applied on the
fourth day following experimental infection.
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Griseofulvin was demonstrated to be effective
in the oral treatment of Trichophyton verrucosum
infections in calves by Lauder and O'Sullivan (9).
Gentles (7) reported the presence of extract-
able griseofulvin in the hair of guinea pigs fed
30 to 40 mg/kg. of the antibiotic for twenty-three
consecutive days. The hair was extracted and
purified by a complex methanol refiuxing process.
An aqueous extraction purified by treatment
with petroleum and benzene followed by meth-
anol and ethanol treatment was also employed.
One gram of hair yielded between 5 and 6 meg.
of griseofulvin. He believes that the elimination
of the dermatophytes from infected hair is due
to the incorporation of griseofulvin in the keratin
where it forms a barrier to further invasion by
the fungus.
Brian (10) reported that many fungi with
chitinous cell walls demonstrated "curling" of
their hyphae when exposed to griseofulvin-
containing media. Those fungi with cell walls of
cellulose failed to demonstrate this effect.
Griseofulvin was not taken up nor translocated
by the mycelium of Phycomyces blakesleeanus in
work reported by Abbot and Grove (11). Al-
though this fungus has a chitinous cell wall, no
"curling" was observed in either the mycelium
submerged in a medium containing griseofulvin
or in the aerial hyphae. Further evidence shows
that no antibiotic is adsorbed on the mycelium
or stored by the mycelium. These workers be-
lieve that degradation of griseofulvin is probably
due to fungal enzyme activity in the medium or
at the surface of the hyphae. It would appear
doubtful that the mere presence of chitin in the
hyphal wall insures the sensitivity of a fungus
to griseofulvin.
Our initial report (12) of 31 human cases of
dermatomycoses showed the antibiotic to be
highly effective when administered in oral doses
of 1 gm. per day. The drug appears to be of low
toxicity in man and no contraindications were
observed. Paget and Walpole (13) reported that
large intravenous doses of griscofulvin in rats
initiated cytotoxic effects. These cytologic ef-
fects resulted in mitotic arrestments and were
similar to those produced by colchicine. In our
recent report on 200 patients (14), no cytotoxie
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effects of griseofulvin were observed as measured
by blood and sperm counts.
Williams et al. (15) and Riehi (16) have simi-
larly reported the efficacy of griseofulvin in the
treatment of human cases of dermatomycoses.
MATERIALS AND METHODS
The fungi employed in this study were grown
in flasks of glucose-peptone-yeast extract broth
on a Gyrotary shaker at 24°C. The time required
for the desired amount of growth varied with the
species; 4 to 6 day old cultures proved to be most
satisfactory for our purposes. Under these condi-
tions of cultivation, the filamentous fungi develop
as discrete hyphal aggregates or pellets. At four
to six days all but the slowest growing forms pro-
duce pellets averaging approximately 1.0 mm. in
diameter. For use the broth was poured from the
flask and the pellets were washed twice for fifteen
minutes with sterile saline. The pellets were re-
suspended in a third volume of saline and the flask
contents poured into a Petri dish.
Two procedures were used for the determina-
tion of the degree of sensitivity of a fungus to
griseofulvin: (I). Test tnbe assay procedure.—One
volume of double strength glucose -peptone-yeast
extract broth was delivered into each tube in the
series. The tubes used measured 20 mm. by 125
mm. and had a screw cap. Sterile standard griseo-
fulvin solution was then delivered into the tubes
to achieve the desired concentration but not to ex-
ceed one volume unit. The preparation of the
griseofulvin solution varied with the requirements
of the particular assay. For stock solutions with an
antibiotic concentration of 25 meg/mI. or less,
sterile demineralized water was used as the sol-
vent. When higher concentrations were needed, the
griseofulvin was first dissolved in a small volume
of ethyl alcohol or N,N-Dimethylformamide and
the solution brought to final volume with water.
The stock solutions of the antibiotic were steril-
ized either by filtration or autoclaving. The
deficiency between the quantity of antibiotic
solution added and one volume unit was made up
with sterile water. In most assays a volume unit
was 2.0 ml. to give a total assay volume of 4.0 ml.
in the tubes. After thorough mixing, a fungal
pellet was introduced into each tube. The pellet
was then measured in at least two diameters with
a stereomicroscope. Measurements were made
twice a day for the duration of the incubation
period. The tube method proved to be most useful
for screening fungi for sensitivity and for obtain-
ing differential values in the magnitude of 0.05
to 0.1 mcg./ml. (2). Plate assay procedure.—In this
method, plates measuring 3.25" by 4" with nine
wells of 7/8" diameter were employed. The plates
were sterilized in 150 mm. Petri dishes along with
a disc of wet heavy absorbant paper to retard
evaporation. Serial dilutions of the standard
griseofulvin were prepared with water and the unit
volume of double strength broth added. Into a well
of the plate 0.5 ml. of each antibiotic concentra-
tion was pipetted. One well received the assay
broth only, to serve as a normal growth control. A
washed pellet of the fungus to be assayed was in-
troduced into the center of each well. The diameter
of each pellet was measured microscopically with
a micrometer eyepiece. The plates and tubes were
maintained at 30°C. in an incubator with a high
humidity to retard evaporation. The measure-
ments of the pellets were repeated twice a day and
the physical characteristics of the advancing
peripheral hyphae of the pellet noted. The plate
assay technic was found to be more sensitive and
accurate than the tube method. The difference in
antibiotic concentration from well to well can be
of the magnitude of 0.01 to 0.02 mcg./ml. More im-
portant, the higher magnification permitted with
the standard microscope allows more accurate
measurements and visualization of abnormalities
in the structure of the mycelium. With experience
the griseofulvin-induced changes in the peripheral
hyphae can be used as an ancillary determinant
for evaluating retardation of growth.
The unicellular yeasts, bacteria, and the di-
morphic fungi with a yeast growth phase were
assayed by a modified tube method and growth
measured by photometric determination of optical
density.
OBSERVATIONS AND EXPERIMENTAL RESULTS
I. The Effect of Griseofulvin on, the in vitro Growth
of Dermatophytes
Thirteen species of dermatophytes were as-
sayed for sensitivity to griseofulvin by use of
both the tube and the plate assay methods.
Preliminary studies had indicated that very
low concentrations of the antibiotic would be
required to secure the inhibition of these fungi.
Griseofulvin is soluble in water to the extent of
approximately 30 mcg./ml. In that this concen-
tration is far greater than that required for in
vitro inhibition of dermatophytes, the stock
solutions of the antibiotic were prepared with
distilled water without other solvents. Serial
tube assays were run first, employing a concen-
tration range of 0.05 to 5.0 mcg./ml. of anti-
biotic in increments of 0.05 meg. The introduced
pellets were measured in cross diameters, twice
daily for eight days. From the results obtained
it became obvious that the establishment of a
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minimal inhibitory concentration value was
directly related to and determined by the length
of the observation period. The effect of increas-
ing concentration of griseofulvin is one of pro-
gressive retardation of the growth rate until a
level is reached at which growth is so slow as to
defy measurement. Thus the longer the period of
incubation and observation, the higher will be
the minimal inhibitory concentration value. The
failure of griseofulvin to produce an "all-or-none"
effect on sensitive fungi all but precludes a sharp
end-point determination independent of time.
For these reasons, two arbitrary observation
time limits were chosen: 72 hours and 160 hours.
In addition, we have observed that it is possible
to decrease the amount of antibiotic required for
inhibition of dermatophytes by limiting or re-
ducing the nutritive value of the assay broth,
especially as to its carbohydrate content. An
assay medium closely approximating that of the
in vivo substrate (stratum corneum, hair, nails)
would probably provide values more realistic
and compatible with the levels required in
therapy.
Based upon the inhibitory values obtained in
the tube procedure, plate assays were prepared
so that the antibiotic concentrations in the wells
of the plates encompassed and bracketed the
tube assay findings. The plate assays covered a
concentration range of 0.1 to 0.5 mcg./ml. in
increments of 0.02 meg. The plates are limited
to an observation time of 96 hours, due to evapo-
ration of well contents which would invalidate
the concentration values. The minimal inhibi-
tory concentration of griseofulvin for the tested
species of dermatophytes is presented in Table 1.
The 72-hour value represents the average of
both the tube and the plate assay results, while
the 160-hour inhibitory concentration is that
obtained with the tube assay only.
With the observation that the dermatophytes
are inhibited by very low concentrations of
griseofulvin, experiments were performed to de-
termine the effect of high concentrations of the
antibiotic on the viability and longevity of these
fungi. Paired flasks containing 100 ml. of saline
with a griseofulvin content of 25 mcg./ml. and
pairs containing glucose-peptone broth with
identical antibiotic concentration each received
fifty washed five-day old pellets of T. rubrum. A
duplicate set of flasks was inoculated with pellets
of T. mentagrophytes. One flask of each pair was
refrigerated at 2°C., the other flask was incu-
TABLE 1
Minimal inhibitory concentrations of griseofulvin
for dermatophittes
Organism At 72 hr. At 160 hr.
Microsporum canis .20—. 24* 1.4_1.6*
Micros poruni gypseum .42—. 46 1.5—1.7
Microsporum Audouini .40—.46 2.1—2.3
Epidermophyton floccosum ,38—.42 2.1—2.3
Trichophyton mentagrophytes .38—.42 1.9—2.1
Trichophyton rubruni .14—.18 1.3—1.5
Trichophyton tonsurans .28—. 32 1.5—1.7
Trichophyton. Megnini .30—.34 2.2—2.4
Trichophyton gailinae .40—.44 2.2—2.4
Trichophyton Schoenleini .34—.38 1.8—2.0
Trichophyton violaceum .36—.40 1.9—2.1
Trichophyton. verrucosum .28—.30 2.1—2.3
Trichophyton. concen.tricum .26—. 30 2.2—2.4
* meg. per ml.
bated at 30°C. On alternate days for thirty days,
three pellets were removed from each flask and
washed three times for fifteen minutes, each
with 10 ml. of sterile saline. After the third
washing procedure, the saline was decanted and
the pellets planted on plates of glucose-peptone
agar. The plates were incubated at 30°C. and
observed daily for development of colonies.
Pellets kept for as long as thirty days at 2°C.
and 30°C. in both saline and broth medium pro-
duced normal colonies on the antibiotic-free
plates. The pellets that had been submerged in
the antibiotic solution for more than ten to
twelve days evidenced a prolonged lag period
(four to six days) before growth became evident
and the initial growth on the agar plates was
somewhat retarded and restricted. Once the
initial phase of retardation had passed, the
growth rate was normal and the colony was
typical in all respects. None of the pellets evi-
denced any signs of growth during the period of
residence in the solution of griseofulvin. In a
subsequent experiment it was observed that a
single washing in 100 ml. of saline for ten minutes
was sufficient to rid the pellet of the antibiotic
and permit the fungus to resume normal growth.
An attempt was made to induce resistance to
griseofulvin in T. rubrum by serially passing the
fungus through progressively higher concentra-
tions of the antibiotic over a prolonged period
of time. Ten washed pellets of the dermato-
phyte, measuring 3 to 4 mm. in diameter, were
placed in a flask containing glucose-peptone
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FIG. lÀ. Periphery of a normal pellet of Trichophyton rubrum, 5 days' growth in gyrotary shaker
culture. The marginal hyphae are rarely branched and fringe out from the central mycelial mass of the
pellet. (unstained; X340).
broth with a griseofulvin concentration of 0.5
mcg./ml. All flasks were maintained on a Gyro-
tary shaker during the course of the experiment.
At the end of seven days of rotation all pellets
had increased to a diameter of 5 to 6 mm. At
this time the hyphal masses were transferred to
fresh broth containing 0.6 meg. of griseofulvin
per ml. Every fifth day thereafter the pellets
were placed in fresh media and the antibiotic
concentration increased 0.1 meg./ml. At the
end of 67 days the fungal pellets were in a broth
containing a griseofulvin concentration of 1.8
meg. /ml. During this period of time the pellets
had slowly increased in diameter, to measure
between 10 and 12 mm.; however, as the anti-
biotic concentration increased, the growth
increment was observed to undergo a progressive
retardation. In a broth with 2.0 meg. of anti-
biotic per ml. no further increase in pellet diam-
eter was detected. Therefore this griseofulvin
concentration was maintained for an additional
six transfers of the pellets at the regular five-day
interval. At the end of this thirty-day period,
the size of the pellets had demonstrated no
measurable increase and appeared to be com-
pletely stationary. The fungal masses were then
washed for six hours in a large volume of sterile
saline and plated on antibiotic-free media where
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Fxo. lB. Marginal hyphae at periphery of normal pellet, T. rubrum. The cytoplasm is fairly homoge-
neous and evenly distributed throughout the hyphal cell; branching is seldom observed. (unstained;
X770).
they developed normal appearing colonies after
an initial dormant period of five to seven days.
The presence of griseofulvin in the medium in
which a dermatophyte is growing is readily de-
tected by marked changes in the growth character
of the mycelium. These induced abnormalities
are depicted in the photomicrographs presented
in Figures 1, 2, and 3. Concentrations as low as
0.05 to 0.1 mcg./ml. produce observable changes
to the experienced microscopist. The first dis-
cernible effect of the presence of griseofulvin at a
concentration of 0.1 meg. /ml. (Fig. 2A) is the
abundant production of short lateral hyphal
projections or branches. The tips of the advanc-
ing peripheral hyphae become slightly swollen
or clubbed (Fig. 2B). As the concentration is
increased to 0.2 to 0.3 mcg./ml. the clubbing
tendency is greatly exaggerated and small con-
tortions and knobs make their appearance (Fig.
3A). Still higher levels (0.5 to 0.6 meg.) result in
the hyphae developing coils or curls (Fig. 3B), as
reported by Brian and co-workers (10), employ-
ing Botrytis allii, and later by Napier with
Alternaria solani, as reported by Gentles (7). At
this point the cytoplasm is highly vacuolated
and many areas in the hyphac have the appear-
ance of autolyzing "ghost cells" (Fig. 3C). In
the region of mature mycelium, swollen balloon-
like cells appear and apparently represent giant
chlamydospores induced by toxicity (Fig. 3D).
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FIG. 2A. Lateral branching and terminal bifurcations observed in marginal hyphae of T. rubrum
pellet exposed to griseofulvin concentration of 0.1 meg/mi. for 72 hours. (unstained; X340).
These abnormal contortions of the hyphae cause
the submerged pellet to change macroscopically
from a sphere with a fluffy or cottony periphery
to one of granular appearance with an irregular
knobbed surface.
II. The in vitro Effect of Griseofulvin on Other
Mycotic Agents, Pathogenic Bacteria, and
Saprophytic Fungi and Yeasts
To determine the spectrum of activity of
griseofulvin for pathogenic fungi, bioassays were
performed, utilizing the etiologic agents of super-
ficial, subcutaneous and systemic mycoses. In
the case of those fungi which are dimorphic, the
assay was performed at both 30°C. with the
filamentous phase and at 37°C employing the
yeast or tissue phase. Glucose-peptone broth
and brain-heart-infusion glucose broth (both
pH 7.0) were prepared by use of a saturated
aqueous solution of griseofulvin (30 mcg./ml.) in
place of distilled water. The broths were gently
heated to dissolve the ingredients and sterilized
by filtration. Flasks containing 20 ml. of the
glucose-peptone-antibiotic broth were inoculated
with three 2-mm. pellets of the fungus to be
tested or with a standardized saline suspension
of the unicellular yeasts. The vessels were sta-
tioned on the gyrotary platform and rotated at
160 rotations per minute. Flasks containing the
medium without antibiotic were similarly inocu-
• •n i
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FIG. 2B. Granular cytoplasm and uneven thickness of cell wall noted in higher power view of pellet
seen in 2A. The clubbing tendency of the hyphal tips and stunting of lateral branches is seen.
lated to serve as normal growth controls. Stand-
ardized inocula of the yeast phase of the di-
morphic forms were inoculated into tubes
containing 10 ml. of the infusion glucose broth
with antibiotic. The tubes were placed in a rack
in water bath shaker set at a temperature of
37°C. Tubes of infusion broth lacking griseofulvin
were inoculated and run concurrently to ascer-
tain normal growth rates. All cultures were
examined twice daily and growth determined as
an increase in pellet diameter, an alteration in
the nature of the pellet periphery, or in the case
of the yeasts and yeast-like forms by an increase
in the optical density. Observations were con-
tinued up to twenty days for the more slowly
growing forms. At the end of the period allowed
for growth, the fungus was examined micro-
scopically for abnormal hyphal configurations or
other signs of inhibition of growth and toxicity.
In no case did the presence of griseofulvin in the
media produce a measurably inhibitory effect on
the growth rate or significantly alter the mor-
phology of the fungi tested. The mycotic agents
tested and found to be unaffected by a concen-
tration of griseofulvin of 30 mcg./ml. are pre-
sented in Table 2.
The observation (17, 18) that certain of the
broad spectrum antibiotics, especially those of
the tetracycline group, markedly enhanced the
pathogenicity of Candida albicans for diverse
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FIG. 3A. Hyphal abnormalities produced in T. rubrum pellet growing for 72 hours in a broth containing
0.25 meg/mI. of griseofulvin. Numerous knobs, contortions and clubbed hyphal tips are in evidence and
growth is greatly inhibited. (unstained; X340).
animal species made it seem advisable to de-
termine whether griseofulvin might have a simi-
lar potentiating effect in experimental candidiasis.
Six groups of ten adult Swiss albino mice were
employed in the study. The mice in the first
group each received a saline solution containing
10.0 meg. of griseofulvin by the intraperitoneal
route. The animals in the second, third, and
fourth groups were injected with 20, 35, and 50
meg., respectively. Ten minutes after the injec-
tion of the antibiotic, 0.5 ml. of a 1:100 washed
cell suspension of a 48-hour culture of Candida
albicans was injected intraperitoneally into all
treated animals. The fifth group of mice received
only the yeast cell suspension, while the members
of the sixth group were administered only 50
meg. of griseofulvin intraperitoneally. The in-
jection of the appropriate amounts of antibiotic
was repeated for three additional consecutive
days. At the end of the eighth day the mice in
all six groups appeared to be in normal health
and upon sacrifice and examination failed to
show any internal lesions or signs of established
candidiasis.
The effect of griseofulvin on the in vitro growth
of various bacteria was investigated. Paired
tubes containing 2.0 ml. of double strength
nutrient broth were prepared. To one tube of
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each pair was added 2.0 ml. of saline containing
60 mcg. of griseofulvin and to the growth con-
trol tube of each pair was added 2.0 ml. of saline
alone. Todd-Hewitt media was used in place of
nutrient broth for Streptococcus pyo genes and
Diplococcus pneumoniae. Each tube was inocu-
lated with 0.1 ml. of a 24-hour culture of the
respective organisms and the amount of growth
evaluated macroscopically after eighteen hours'
incubation at 37°C. The findings are presented in
Table 3. None of the organisms was inhibited in
its growth by griseofulvin in a concentration of
15 meg/mi. Several of the bacteria tested at
first seemed to show an apparent growth stimu-
lation but this effect was found not to be signifi-
cant when tested by quantitative turbidimetric
procedure.
A limited survey employing 22 species of com-
mon saprophytic fungi failed to uncover any
form which demonstrated a significant degree of
inhibition in a high (25 mcg./ml.) concentration
of griseofulvin. The species subjected to bio-
assay and found to be resistant to complete
inhibitory activity by the antibiotic are listed in
Table 4.
A sensitive unicellular microscopic growth
form would be of great value in assaying the
griseofulvin content of body tissues and fluids.
A turbidimetric method would be much more
accurate and workable than one based upon the
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Fio. 3B. Marked inhibition of growth and gross abnormalities induced in marginal mycelium of
pellet of T. rubrum by griseofulvin, 0.5 mcg./ml., 60 hours. (unstained; X340).
r
I,t
412 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
FIG. 3C. Vacuolation and cytoplasmie massing produced in hyphae of T. rubrum exposed to 0.3
mcg./ml. of griseofulvin, 72 hours. Some cells appear to have areas devoid of contents and resemble
autolyzing "ghost cells". (unstained; X770).
inhibition of fungal growth or the engendering of
abnormalities in hyphal morphology. For this
reason 40 species of sexual nd imperfect yeasts
in 16 genera were tested for sensitivity to griseo-
fulvin. Standardized suspensions of washed yeast
cells were inoculated into a series of five tubes of
assay broth containing 1, 5, 10, 15, and 25 mcg.
of antibiotic per ml., respectively. The inocu-
lated tubes were placed in a rack on a gyrotary
shaker platform and incubated at 26°C. The
resultant growth was measured turbidimetrically
in a Lumetron colorimeter at 24, 48 and 72
hours. The species tested are listed in Table 5.
None of the 40 yeasts so tested demonstrated
either inhibition or enhancement of growth of
significant degree by an antibiotic concentration
ranging up to 25 mcg./ml.
III. Effect of Griseofulvin. on the Respiration of
Trichophyton rubrum
To obtain cellular material for respiration
studies, T. rubrum was grown in glucose-peptone
broth at room temperature on the gyrotary
shaker. Most of the strains of the fungus formed
hyphal pellets of varying sizes in five days of
cultivation. Two groups of pellet sizes were
segregated for study: (a) small pellets ranging
from 0.4 to 1.0 mm. in size and (b) larger pellets
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FIG. 3D. Large chiamydospores seen within mature mycelium of fungal pellet of T. rubrum exposed
for 72 hours to griseofulvin, 0.3 meg/mI. (unstained; X770).
1.1 to 2.0 mm. in diameter. In addition to pellet
formation, one strain of 7'. rubrum produced
diffuse mycelial growth on the shaker in the same
time period. Q02 characteristics of these three
types of growth were determined. Prior to War-
burg manometric determination, the five-day
growth was removed from the culture flasks and
washed twice with saline. Standard Warburg
technics were utilized, including the use of 20
per cent KOH in the center well for CO2 absorp-
tion. The Q02 values for the three types of
growth are given in Table 6. The larger pellets
showed respiratory activity more than six times
greater than that of the smaller pellets. The
respiratory activity of the diffuse mycelial growth
was somewhat greater than that of the small
pellets. It was decided to test the effect of griseo-
fulvin on the most active respiring form of the
fungus.
The segregated larger pellets were tested for
the effect of added glucose and griseofulvin indi-
vidually on their respiratory activities. Glucose
was added in the amount of 15 mg. and griseo-
fulvin, 30 meg. per flask. Total flask content was
3.0 ml. The pellets were washed twice in saline
prior to use. From the upper half of Figure 4 it
can be seen that griseofulvin has a very slight
inhibitory effect on oxygen uptake when com-
pared with the endogenous respiration (15 ml.
Q02 over a sixty-minute period). It is not likely
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Organism TePeiat1re of
Candida albicans
Cry ptococcus neoformans
Sporotrichum Schenckii
Hormodendrum corn pactum
Phialophora verrucosa
Nocardia asteroides
Nocardia brasiliensis
Blastomyces derniatitidis
Blastomyces brasiliensis
Histoplasma capsulatum
Geotrichum candidum
Aspergillus fumigalns
28 C. and 37 C.
28 C. and 37 C.
28 C. and 37 C.
28 C.
28 C.
28 C.
28 C.
28 C. and 37 C.
28 C.
28 C. and 37 C.
28 C.
28 C.
TABLE 3
The effect of griseofulvin on the in vitro growth of
various bacteria
.
rgaflism Growthin broth
Growth
in broth
containing
griseoful-
yin (15
mcg/mI)
Aerobacter aerogenes
Bacillus subtilis
Bacillus cereus
Corynebacterium diphtheriae
Escherichia coli
Kiebsiella pneumoniae
Staphylococcus aureus (coagu-
lase positive)
Staphylococcus albus
Proteus vulgaris
Pseudomonas aeruginosa
Salmonella typhirnurium
Salmonella typhosa
Sarcina lutea
Serratia marcescens
Shigella paradysenteriae
Diplococcus pneurnoniae
Streptococcus pyogenes, gp. A
Streptococcus pyogenes, gh. C
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that the observed, very limited effect of griseo-
fulvin on the respiration of the dermatophyte
could account for the marked growth inhibition
obtained with much smaller amounts of the anti-
biotic. The addition of glucose to the washed
fungal cells does not increase respiration, indi-
cating that the fungal cells of the large pellet
TABLE 4
Effect of griseofulvin (25 mcg./ml.) on the growth
of various fungi
size contain sufficient readily available carbo-
hydrate reserves to account for all the cellular
energy needs of the organism, at least during
the period of observation. Although it appears
from Figure 4 that the respiration inhibition of
T. rubrum is practically as great following the
addition of glucose as is that following griseoful-
yin, replicate experiments continually showed
the slight inhibitory activity of griseofulvin,
whereas the glucose inhibition was sufficiently
erratic to be ascribed to experimental variation.
To determine whether the failure of griseo-
fulvin to affect the respiration of T. rubrum might
be due to the failure of cellular penetration by
the antibiotic, large hyphal pellets were homoge-
nized for a brief period in a Virtis homogenizer.
The homogenized cells were then treated as the
intact pellets had been. The results are visualized
by graphs in the lower half of Figure 4. It can
be seen that the endogenous respiration follow-
ing homogenization is reduced approximately by
half. The intact cell is apparently a major re-
quirement for reasonably normal metabolic
activity. Griseofulvin addition showed no ac-
tivity at all on the cytoplasmic energy centers,
indicating in conjunction with its small activity
on the intact hyphal cells, that if the antibiotic
TABLE 2
Pathogenic fungi uninhibited by griseofulvin,
30 rncg./ml.
Alternaria tenuis
Aspergillus candidus
Aspergillus glaucus
Aspergillus niger
Aspergillus terreus
Curvularia geniculata
Fusarium oxysporurn
Helminthosporiurn anorna-
turn
Helminthosporium sat ivum
Hormodendrum olivaceurn
Mucor genevensis
Oospora variabilis
Paecilomyces divaricatum
Penicillium nigricans
Penicillium janthinellum
Penicillium chrysogenurn
Phoma humicola
Rhizopus nigricans
Scopulariopsis cornmunic
Scopulariopsis brevicaulis
Trichoderma koningi
Slight inhibition
No inhibition
Slight inhibition
No inhibition
No inhibition
Slight inhibition
No inhibition
Slight inhibition
Slight inhibition
Slight inhibition
No inhibition
No inhibition
No inhibition
No inhibition
No inhibition
No inhibition
Slight inhibition
No inhibition
No inhibition
No inhibition
No inhibition
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TABLE 5
Yeasts uninhibited or enhanced in growth by
griseofuivin concentration of 25 meg/mi.
Pichia beigica
Pichia chodati
Saceharomyces bayanus
Saccharomyces earls-
bergensis
Saccharomyces cere-
visiae
,Saccharomyces ellip-
soideus
Saccharomyces fragilis
Saccharomyces italicus
Schizosaccharomyces
ostos pores
Schizosaccharomyces
pombe
Rhodotroula giutinus
Rhodotroula mucilagi-
nosa
affects energy mechanisms at all it is at a more
superficial locus, most probably in the cell wall
area. The addition of glucose to the homogenate
enhanced respiration slightly, indicating that
the carbohydrate reserves present in the large
pellet cells were probably removed in small
measure by rupture of the cell and by the two
saline washings.
IV. The Bioassay of Griseofuivin in Body
Fiuid.s and Tissues
During the course of this study direct bioassays
of 126 sera obtained from patients and normal
volunteers on various dosage levels of griseofulvin
were performed. In addition, 85 urine samples
from the same subjects were subjected to bio-
assay, utilizing pellets of T. rubrum in both the
tube dilution method and the well-plate technic.
Diffuse mycelial growth
Small hyphal pellets (0.4—1.0 mm.)
0.75
0.39
Large hyphal pellets (1.0—2.0 mm.) 2.49
basis.
In our experience these procedures are at best
insensitive and inaccurate methods for the de-
termination of blood and excretion levels of the
drug. In the blood, and to a lesser extent in the
urine, are found normal substances and factors
which interfere with growth of dermatophytes to
thus complicate assessment of true griseofulvin
activity. From our data as obtained by bioassay,
it would appear that body fluid and urine levels
are rarely in excess of 1 to 2 mcg./ml. and most
commonly are considerably lower (0.2 to 0.5
meg. /ml.). Therefore in the direct assay of serum
and urine one must employ concentrations of the
fluids which in themselves possess a significant
capacity to inhibit fungal growth and evoke
some morphologic alterations in hyphal structure.
In a limited study the abnormal changes in the
microscopic character and structure of the my-
celium as induced by griseofulviri were employed
as the criteria for determination of the antibiotic
concentration. This approach has some merit
but was found to be laborious and somewhat
cumbersome. A further difficulty was encoun-
tered in correlating consistent and defined
changes in fungal morphology with small differ-
ences in the concentration of the antibiotic in
the sample. The microscopic method requires a
considerable amount of experience and is subject
to significant variation as to individual observers.
In addition, the inhibitory action of normally
occurring factors in body fluids is difficult to
assess and distinguish from those induced by the
griseofulvin itself.
A comparison of the concentration levels ob-
tained by bioassay with those reported by
chemical extraction and spectrophotometric
procedures would suggest that a significant
amount of the antibiotic in body tissues and
fluids may occur in a form lacking biological
activity for the dermatophytes. If, however, the
TABLE 6
Endogenous respiratory quotients of trichophyton
rubrum in various growth stages obtained
in shaker culture
Air* Q02
* Q02 values are calculated on a dry weight
Candida flareri
Candida guilliermondi
Candida krusei
Candida krusoides
Candida macedoniens
Candida monosa
Candida parakrusei
Candida parapsilosis
Candida pseudotropi-
calis
Candida tropicalis
Candida zeylandoides
Cryptococcus nigricans
Debar yomyces kiockeri
Debar yomyces mem-
branefaciens
Endomyces magnusii
Endomycopsis iindneri
Eremothecium ashbyii
Hansenula saturnus
Mycoderma lafarii
Mycoderma vini
Torulaspora rosei
Torulopsis puicherrima
Trigonopsis variabilis
Zygosaccharomyces
acidifaciens
Zygosaccharomyces
casei
Zygosarcharomyces del-
bruckii
Zygosaccharomyces
lactis
Zygosaccharomyces
marxianus
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FIG. 4. Effect of griseofulvin on oxygen uptake by Trichophylon rubrum
low levels detected by measurement of the body
fluids' capacity to inhibit sensitive fungi are
valid they may reflect only the low aqueous
solubility of griseofulvin. Similarly, the absorp-
tion of the orally administered antibiotic may be
restricted and the drug once absorbed from the
gastrointestinal tract may be quickly incorpo-
rated in or fixed by diverse body tissues.
With the observation that the action of griseo-
fulvin on dermatophytes was apparently limited
to that of fungistasis, a re-evaluation of the per-
sistanee of viable though arrested fungi in the
skin of patients undergoing therapy was under-
taken. It was reasoned that the keratin of the
stratum eorneum of these individuals could con-
tain a sufficient depot of antibiotic to thus con-
tinue to inhibit static fungal elements even when
grown on a favorable medium. Such a condition
might lead to erroneous information concerning
the duration of treatment or dosage needed to
affect a cure as determined by obtaining a nega-
tive culture. To test this concept, six patients
with tinea corporis due to 7'. rubrum were treated
with griseofulvia. At regular intervals the areas
of the lesions were seaped thoroughly and
the skin pooled. Half of the sample was plated
directly upon routine solid media contain-
ing eyeloheximide and chloramphenieol. The
other half of the material was washed in three
separate changes of 5 per cent N ,N-dimethyl-
formamide in saline for thirty minutes each. The
last wash was decanted and the skin in the tube
overlayed with routine glucose-peptone broth
containing the mentioned antibiotics. It was felt
that the washing procedure employed a solvent
for griseofulvia and subsequent use of a liquid
medium would be sufficient to wash out or lower
the concentration of the antibiotic so that an
inhibitory carry-over effect would be eliminated.
The results secured have not been of sufficient
magnitude to justify a definitive conclusion.
However, an approximate equal number of
positive cultures have been secured by each
method and both have been positive 25 per cent
of the time. At this point it would not appear
that an extraction of griseofulvin from clinical
material is necessary prior to cultivation. The
findings merely re-emphasize the need for mul-
tiple cultures and employment of diverse media
to best insure the isolation of these myeotic
agents.
The direct bioassay of serum from individuals
receiving orally administered griseofulvin indi-
cated that the blood level was very low or that
the antibiotic might be present, at least in part,
in a form not possessing in vitro inhibitory
activity for dermatophytes. To test the possi-
bility that serum may bind or complex with the
antibiotic to thereby reduce its activity, 10 ml.
of normal human serum was combined with 10
ml. of a saline solution of griseofulvin containing
the antibiotic at a concentration of 20 meg. /ml.
The serum-antibiotic mixture was placed in a
water bath shaker at 37°C. for twelve hours. At
the end of this time the mixture was assayed by
the tube method against T. rubrum. The assay
125
100
75
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GLUCOSE ADDED
GRISEDEUL V/N ADDED
GLUCOSE ADDED
ENDDGENDUS
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20
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series was incubated for 72 hours at 30°C. At
the conclusion of the incubation it was observed
that 0.2 ml. of the serum-antibiotic mixture per
ml. of broth was required to inhibit the fungal
pellet. This volume ratio represents an anti-
fungal antibiotic concentration of 2.0 mcg. /ml.
In contrast, the same relative degree of pellet
inhibition was secured with 0.2 mcg./ml. of
griseofulvin when the assay was conducted di-
rectly with the saline solution of the antibiotic.
These results indicated that approximately ten
times more griseofulvin was needed for the
inhibition of T. rubrum. following an incubation
of the antibiotic with 50 per cent serum. As
measured by its inhibitory potential for dermato-
phytes it would appear that griseofulvin is
partially inactivated or removed by in vitro con-
tact with human serum.
5UMMAEY
Thirteen of the recognized species of dermato-
phytes demonstrated a high degree of in vitro
sensitivity to griseofulvin. Low concentrations of
the antibiotic inhibited their growth and pro-
duced bizarre abnormalities in their hyphal
structure. Higher levels of the antibiotic resulted
in an apparent complete arrestment of the growth
of the mycelium.
The action of griseofulvin on dermatophytes
appears to be limited to that of fungistasis in
that these fungi were able to withstand pro-
longed exposure to high concentrations of the
antibiotic without loss of viability.
Griseofulvin failed to demonstrate significant
in vitro inhibitory activity against the etiologic
agents of histoplasmosis, North and South
American blastomycosis, candidiasis, chromo-
blastomycosis, nocardiosis, geotrichosis, asper-
gillosis, cryptococcosis and sporotrichosis.
The intraperitoneal administration of griseo-
fulvin to white mice experimentally infected with
Candida albicans did not result in the death of
any of the animals nor appear to enhance the
severity of the infection.
All tested species of non-pathogenic ascosporo-
genons and imperfect yeasts and yeast-like fungi
were completely resistant to high concentrations
of griseofulvin.
Griseofulvin in high concentration did not
affect the growth of a select group of pathogenic
bacteria.
Griseofulvin had a very slight but consistent
inhibitory effect upon the respiration of intact
cells of Trichophyton rubrum, whereas the cyto-
plasmic energy centers were not affected at all.
The addition of griseofulvin to normal serum
appeared to result in a decline in the activity
of the antibiotic as determined by subsequent
bioassay.
The direct bioassay of body fluids was gen-
erally unsatisfactory due to the low levels of
detectable antibiotic present in such materials
and the presence of normal interfering substances.
In the cultivation of skin scrapings from
patients on griseofulvin therapy for evidence of
biological cure, the antibiotic content of the skin
does not appear to be a factor for concern since
direct inoculation of skin from such individuals
on appropriate media did not result in the in-
hibition of the resident fungus.
An attempt to induce resistance to griseofulvin
in Trichophyton robrum by subculturing the
organism in gradually increasing concentrations
of the antibiotic over a prolonged period of time
was not successful.
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